A post-hoc analysis presented at the American College of Cariology’s Annual Scientific Session suggests that maintaining functional stability, measured by 6-minute walk distance, is associated with lower...
New guideline recommendations from the ACC/AHA and 9 partner organizations prioritize earlier treatment, refined atherosclerotic cardiovascular disease risk prediction, and broader use of lipid biomarkers...
In a post-hoc analysis of ATTR-ACT, investigators examined whether baseline National Amyloidosis Center (NAC) stage influences long-term mortality, cardiovascular outcomes, and health status in patients...
A new cost-effectiveness modeling study evaluates whether coronary artery calcium scoring can refine cardiovascular risk stratification and help identify obese patients most likely to derive clinical and...
The FDA has cleared a once-daily oral semaglutide treatment for adults with obesity or overweight and weight-related conditions, based on phase 3 OASIS 4 trial results demonstrating significant mean weight...
A new ACC/AHA clinical practice guideline on managing adults with congenital heart disease updates its 2018 recommendations by integrating evidence from 2017 to 2024 and emphasizing specialized...
A large systematic review and meta-analysis published in the Journal of the American Heart Association evaluated evidence from 155 studies worldwide, identifying strong associations between several viral...
A new multicenter randomized clinical trial published in JAMA evaluated whether consuming caffeinated coffee affects the recurrence of atrial fibrillation (AF) after cardioversion. The findings suggest that...
A phase 2 clinical trial found that ataciguat, a soluble guanylate cyclase activator, may slow aortic valve calcification and help preserve cardiac function in patients with moderate calcific aortic valve...
